Has Lenny Stubbs, MD received payments from drug or device companies?

Yes. Drug and device makers reported $55,532 in general payments to Lenny Stubbs, MD across 41 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lenny Stubbs, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lenny Stubbs, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lenny Stubbs, MD

Vascular Surgery · Oklahoma City, OKNPI 1942297817

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (36.0%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Globus Medical accounts for 97.3% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $43,177 and has fallen 99.6% since, to $151 in 2025. Among vascular surgery clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$55,532in general payments, 2019–2025

Across 41 payments — averaging $1354.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Globus Medical$54K
Silk Road Medical, Inc.$1K
W. L. Gore & Associates, Inc.$151
Stryker$84
Medtronic$53
Artivion, Inc.$12
plus $11 from 1 others

$14,500in research payments, 2019–2025

Across 16 payments — averaging $906.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

W. L. Gore & Associates, Inc.$15K

What the payments were for

Royalty or licence$20,00036%
Consulting fees$15,60028%
Speaking & faculty fees$2,4004%
Travel & lodging$16,02429%
Food & beverage$1,5083%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Globus Medical	27	$54,033
Silk Road Medical, Inc.	8	$1,188
W. L. Gore & Associates, Inc.	1	$151
Stryker	1	$84
Medtronic(2 entities)	2	$53
Artivion, Inc.	1	$12
Getinge USA Sales, LLC	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ALIF$35,838
XLIF$24,884
ENROUTE Transcarotid Neuroprotection System$964
ENROUTE Transcarotid Stent System$964
ENHANCE Transcarotid Peripheral Access Kit$964
ENROUTE 0.014 Guidewire$964
GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$151
BASE$151
RELINE$138

How this compares

$55,532 in reported general payments places this provider in the 90th percentile of 35 vascular surgery providers in Oklahoma.

See all vascular surgery providers in Oklahoma →

Medicare billing

Part B allowed, 2024

$170,334

Medicare patients

264

Services billed

535

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	29	$22,964
XareltoRivaroxaban	17	$11,747
Cilostazol	112	$1,981
ClopidogrelClopidogrel Bisulfate	127	$1,321
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	74	$655
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	47	$448
Oxycodone Hcl	41	$244
Mupirocin	16	$173
Doxycycline Monohydrate	13	$163
Ciprofloxacin Hcl	11	$140
Warfarin Sodium	12	$85
Tramadol Hcl	11	$34

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Oklahoma City

Jim MeltonOklahoma City$131K
Ali AminOklahoma City$41K
Bernardino RochaOklahoma City$34K
Clifford HowellOklahoma City$17K
Sherisa WarrenOklahoma City$15K
Jones ThomasOklahoma City$14K
Trenton KinnearOklahoma City$10K
Donald SpadoneOklahoma City$9K
James NeelOklahoma City$7K
Whitney ThorneOklahoma City$7K

See the full list for Oklahoma →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →